XenoPort gets Japanese rec for RLS med; Sri Lanka plots price controls;

 @FiercePharma: Sanofi abandons authorized Lovenox generic, now that Amphastar's copy isn't a threat to brand sales--Bloomberg. More | Follow @FiercePharma

> XenoPort won a recommendation from Japanese regulators for its restless legs syndrome treatment, to be marketed under the name Regnite; the drug is sold in the U.S. by GlaxoSmithKline ($GSK) as Horizant. Article

> The Sri Lankan government is planning a new price-control program on drugs to begin next month. News

> Mylan ($MYL) won final FDA approval for its version of the Pfizer ($PFE) injectable for hemophilia patients, Cyklokapron. Item

> Hungary's Gedeon Richter nabbed exclusive distribution and marketing rights for the uterine treatment Esmya in Russia, China and several other markets. Story

> Britain's FDS Pharma bought SciGen Israel's Rehovot plant for $2 million plus 5 royalties on the hepatitis vaccine made there. Report

> China's Guangdong Taiantang Pharmaceutical plans to buy Chaozhou Shanyuan Investment for 136 million yuan, giving it an indirect 52.4% stake in Guangzhou Hongxing Group, a well-known Chinese brand that makes patented drugs. More

Biotech News

 @FierceBiotech: Novartis aiming to impress investors, academics as it presents flurry of data on its growing cancer franchise. Article | Follow@FierceBiotech

 @RyanMFierce: Profile on former Icahn biotech lieutenant Alex Denner via Bloomberg--Still not many details on his hedge fund. Item | Follow @RyanMFierce

 @JohnCFierce: U.K. offering $280M catalyst fund, patient data access for biotech R&D. Story | Follow @JohnCFierce

 @MarkHFierce: The Aussies have found a gene that stops skin cancer. Treatments could follow in 5 years? We'll see. More | Follow @MarkHFierce

> Affymax investors bullish on FDA review of Amgen anemia drug rival. News

> Can Denner's new hedge fund replicate Icahn's golden biotech touch? Article

Medical Device News

> Integra opens Shanghai office. News

> Qualcomm unit to provide wireless solutions for devices. More

> Moog taps Scannell as CEO. Item

IT News

> Microsoft co-founder Allen urges open science to speed breakthroughs. Story

> Startup Spiral Genetics takes shot at bioinformatics. Article

> AstraZeneca taps IT outsourcing firm Cognizant. News

And Finally... A salary dispute with doctors at Slovakian hospitals has been resolved, saving the country's medical system from breakdown. News

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.